340B program compliance seems to become more complicated each year, with new reporting obligations, scrutiny, and expectations. Even seasoned 340B program health center staff can feel overwhelmed by the volume and pace of developments in the program. HRSA has announced a new rebate model for certain commonly prescribed drugs beginning January 1, 2027, which further complicates the landscape.
This workshop will view the program’s patient definition, Medicaid and Medicare billing requirements, and 340B discount access through a 2026 lens. In addition, it will take a deep dive into more advanced 340B program topics, including inventory management, pharmacy and third-party administrator contracting, and identifying opportunities to expand services to patients through telemedicine and new service lines.
Session 1 will focus on 340B program requirements as they are being applied in 2026.
1250 Connecticut Ave, NW
Eighth Floor
Washington DC 20036
Tel: (202) 466-6550
Fax: (202) 792-6540
Email: info@powerslaw.com
Privacy | Terms of Use
© Powers Pyles Sutter and Verville PC 2026. All rights reserved. 1250 Connecticut Ave NW | Eighth Floor | Washington, DC 20036 | 202.466.6550 | Fax 202.792.6540 Web Design by Orpheus, Inc.